person
Concetta M.
- Country
- Italy
- Department
- IRCCS Istituto G. Gaslini
Research Overview
assignment
7
Clinical Trials ·
- International Pediatric Study of Arsenic Trioxide and Tretinoin ± Gemtuzumab Ozogamicin for Acute Promyelocytic Leukemia in Children and Adolescents
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children - Sub-protocol D
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
149
Sites with multiple studies
Has run more than one trial at 149 of 199 partner sites.
Specializations
Pediatric Leukemia Research
This investigator specializes in treating acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in children and adolescents, with particular emphasis on high-risk and relapsed cases.
- Philadelphia chromosome-positive ALL treatment protocols
- Infant-specific ALL interventions
- FLT3-mutated AML therapies
Advanced Therapeutic Approaches
The investigator focuses on innovative treatment combinations incorporating targeted immunotherapies and molecular-based interventions for hematologic malignancies.
- Proteasome inhibitor applications
- JAK-STAT pathway targeting
- MAPK/SRC signaling interventions
Refractory Disease Management
Expertise in treating resistant and relapsed hematologic conditions, with focus on developing novel therapeutic strategies for challenging cases.
- Combination therapy protocols
- Molecular anomaly-based treatments
- High-risk disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.